Sandhill Capital Partners’s Cantel Medical Corporation CMD Stock Holding History

Sandhill Capital Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-108,930	Closed	-$12.1M	–	79
2018 Q1	$12.1M	Sell	108,930 -39,781	-27%	-$4.46M	1.99%	26
2017 Q4	$15.3M	Sell	148,711 -17,330	-10%	-$1.73M	2.72%	20
2017 Q3	$15.6M	Buy	166,041 +3,013	+2%	+$238K	3.05%	17
2017 Q2	$12.7M	Buy	163,028 +11,747	+8%	+$882K	2.68%	21
2017 Q1	$12.1M	Buy	151,281 +8,739	+6%	+$695K	2.83%	22
2016 Q4	$11.2M	Sell	142,542 -20,980	-13%	-$1.63M	3.08%	17
2016 Q3	$12.8M	Buy	163,522 +117	+0.1%	+$8.49K	3.83%	13
2016 Q2	$11.2M	Buy	163,405 +3,045	+2%	+$210K	3.52%	15
2016 Q1	$11.4M	Sell	160,360 -1,391	-0.9%	-$87.3K	3.76%	15
2015 Q4	$10.1M	Sell	161,751 -87,809	-35%	-$5.36M	3.2%	20
2015 Q3	$14.2M	Buy	249,560 +6,830	+3%	+$362K	4.73%	4
2015 Q2	$13M	Buy	242,730 +13,648	+6%	+$664K	3.99%	11
2015 Q1	$10.9M	Buy	229,082 +9,469	+4%	+$419K	3.7%	15
2014 Q4	$9.5M	Buy	219,613 +4,197	+2%	+$171K	3.22%	18
2014 Q3	$7.41M	Buy	215,416 +5,643	+3%	+$199K	2.64%	21
2014 Q2	$7.68M	Buy	+209,773	New	+$7.12M	2.78%	20

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Sandhill Capital Partners's CMD Position: Q2 2018 in Review

Sandhill Capital Partners sold out of Cantel Medical Corporation (CMD) in Q2 2018, closing a stake of 108,930 shares — an estimated $12.1M sold.

Sandhill Capital Partners first reported a position in CMD in Q2 2014 and held it in 16 quarters. The position peaked at $15.6M in Q3 2017. 292 funds tracked by Wall St. Rank hold CMD as of Q2 2018.

Sandhill Capital Partners reported no remaining Cantel Medical Corporation position as of Q2 2018 after selling out during the quarter.
Sandhill Capital Partners sold 108,930 Cantel Medical Corporation shares in Q2 2018, an estimated $12.1M.
Sandhill Capital Partners first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 16 quarters.
Sandhill Capital Partners's Cantel Medical Corporation position peaked at $15.6M in Q3 2017.
292 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2018.

Based on Sandhill Capital Partners's 13F filing for Q2 2018, filed 13 Aug 2018.